Biomarkers and personalized medicine in heart failure

    Onderzoeksoutput

    753 Downloads (Pure)

    Samenvatting

    Treating heart failure is one of the greatest unmet needs in cardiovascular medicine today. Overall survival is poor and 50% of patients die within 5 years of their initial diagnosis. Heart failure is a heterogeneous syndrome and a one-size-fits-all approach is ineffective. Therefore, in my thesis I used biomarkers to 1. Show that patients with heart failure and a preserved ejection fraction are subject to more inflammation, which can be a key treatment target and 2. Identified clinical relevant subgroups with differences in response to treatment using machine learning based approaches.
    Originele taal-2English
    KwalificatieDoctor of Philosophy
    Toekennende instantie
    • Rijksuniversiteit Groningen
    Begeleider(s)/adviseur
    • van der Meer, Peter, Supervisor
    • Voors, Adriaan, Supervisor
    • Brunner-La Rocca, Hans-Peter, Beoordelingscommissie, Externe Persoon
    • van Gilst, Wiek, Beoordelingscommissie
    Datum van toekenning17-sep-2018
    Plaats van publicatie[Groningen]
    Uitgever
    Gedrukte ISBN's978-94-034-1064-7
    Elektronische ISBN's978-94-034-1063-0
    StatusPublished - 2018

    Citeer dit